On heels of U.S. pact, Johnson & Johnson strikes a double-size COVID vaccine deal with Europe

Just one week after inking a COVID-19 vaccine deal with the U.S. for 100 million doses, Johnson & Johnson reached a supply agreement twice that size with the European Union.

In a pact unveiled Thursday, J&J agreed to supply the EU with 200 million doses of its coronavirus vaccine candidate—if the program succeeds in testing. The parties didn’t release financial terms, and the agreement includes an option for an additional 200 million doses.